Navigation Links
Poniard Pharmaceuticals Reports Third Quarter 2009 Financial Results and Provides a Corporate Update
Date:11/3/2009

luted 34,769 34,688 34,723 34,685 ====== ====== ====== ====== Condensed Consolidated Balance Sheets (In thousands) September 30, December 31, 2009 2008 -------------- ------------- (Unaudited) (Note 1) ASSETS: Cash and investment securities $40,114 $72,755 Cash - restricted 281 281 Facilities and equipment, net 277 1,123 Licensed products, net 7,896 8,807 Other assets 1,072 1,266 ----- ----- Total assets $49,640 $84,232 ======= ======= LIABILITIES AND SHAREHOLDERS' EQUITY: Current liabilities $17,574 $19,178 Long term liabilities 11,848 17,407 Shareholders' equity 20,218 47,647 ------ ------ Total liabilities and shareholders' equity $49,640 $84,232 ======= ======= Note 1: Derived from audited financial statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2008.

SOURCE Poniard Pharmaceuticals, Inc.


'/>"/>
SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Poniard Pharmaceuticals to Present at the 2009 UBS Global Life Sciences Conference
2. Poniard Pharmaceuticals Announces Pivotal Phase 3 SPEAR Trial Evaluating Picoplatin in Small Cell Lung Cancer Reaches 320th Event Target
3. Poniard Pharmaceuticals To Present at Three Upcoming Investor Conferences in September
4. Poniard Pharmaceuticals Reports Second Quarter 2009 Financial Results and Provides a Corporate Update
5. Poniard Pharmaceuticals to Host Second Quarter 2009 Financial Results Conference Call on August 4
6. Poniard Pharmaceuticals Appoints Gary A. Lyons to Board of Directors
7. Poniard Pharmaceuticals to Present at the 8th Annual Needham Life Sciences Conference
8. Poniard Pharmaceuticals Files Shelf Registration
9. Poniard Pharmaceuticals to Present at the Leerink Swann Oncology Roundtable Conference
10. Poniard Pharmaceuticals to Present at the 2009 BIO International Convention
11. Poniard Pharmaceuticals Presents Final Results of Phase 1 Study of Picoplatin in Patients with Metastatic Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... , Jan. 23, 2015  Array BioPharma Inc. (NASDAQ: ... reached a definitive agreement with Novartis Pharma AG to ... currently in Phase 3 development.  This agreement is conditional on ... PLC (GSK) on April 22, 2014, which are expected to ...
(Date:1/22/2015)... COLUMBIA, Md. (PRWEB) January 22, 2015 ... of its new UV-1280 multipurpose UV-visible spectrophotometer. Offering ... compact, high-quality instrument is ideal for applications in ... and life science. , The user-friendly UV-1280 enables ...
(Date:1/22/2015)... 22, 2015  Transwestern | RBJ today announces the firm brokered ... for Shire a leading biopharmaceutical company, at Two Ledgemont Center ... Robert Richards , president, and Brian Cohen , ... entire five-floor building at 95 Hayden Ave. Photo ...
(Date:1/22/2015)... January 22, 2015 Protocol Networks brings ... growing team of brand-neutral, independent consultants, Protocol Networks has ... explained that over the years, his company has attracted ... Town of Plainfield, as well as others. With the ...
Breaking Biology Technology:Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 2Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 3Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 4Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 5Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 6Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 7Shimadzu’s New Monitored Single-Beam UV-Vis Spectrophotometer Offers Comprehensive Measurement Options in a Compact Body 2Transwestern?RBJ Advises Shire in 202,000 SF Lease, Creating Boston's Largest Suburban Biotech Campus 2Protocol Networks Brings Independent Technology Consulting to the Constitution State 2
... Childhood Cancer Research Organization Looks to CMM for,Professional ... Treatment, GRAND RAPIDS, Mich., Jan. 8 ... has been selected by the Children,s,Oncology Group (COG) ... of a study to evaluate the existence of ...
... Jan. 8 Substantial progress and,momentum behind its research-and-development ... deliver several new blockbuster products to farmers,by 2012, company ... part of a series of presentations on the company,s ... to see such innovation in the pipeline right now," ...
... of leading treatment planning software developer would, strengthen Elekta,s ... ... STOCKHOLM, Sweden, Jan. 8 Elekta AB (publ) (STO: ... today announced that it is in exclusive negotiations based on,a ...
Cached Biology Technology:Center for Molecular Medicine Selected to Provide DNA Analysis for Children's Oncology Group Leukemia Study 2Center for Molecular Medicine Selected to Provide DNA Analysis for Children's Oncology Group Leukemia Study 3Center for Molecular Medicine Selected to Provide DNA Analysis for Children's Oncology Group Leukemia Study 4Monsanto's R&D Pipeline Set to Deliver Valuable Products to Farmers Well Into Next Decade 2Monsanto's R&D Pipeline Set to Deliver Valuable Products to Farmers Well Into Next Decade 3Elekta Negotiates To Acquire CMS 2Elekta Negotiates To Acquire CMS 3Elekta Negotiates To Acquire CMS 4Elekta Negotiates To Acquire CMS 5
(Date:12/17/2014)... Valencell, a leader in performance biometric data sensor technology, ... such as Intel, Jabra, Atlas, and Scosche to develop ... products will be showcased at CES 2015, taking place ... "Our partners choose PerformTek biometrics, because ...
(Date:12/15/2014)... , Dec. 12, 2014 Research and Markets ... the "Global Facial Recognition Market 2015-2019" report ... Facial recognition is a technology used ... the overall facial feature of a person such as ...
(Date:12/11/2014)... , Dec. 10, 2014  That blood pressure plays a role ... Hypertension – the medical term for high blood pressure – ... and the inflatable cuff that,s used in measuring blood pressure ... there,s nothing new about hypertension, its triggers and its effects. ...
Breaking Biology News(10 mins):Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4
... the Three Musketeers who lived by the motto "All ... do their own thing. For years, debate swirled around ... a central growth regulatory module. Now, the cooperation model ... Biological Studies. They show that each hormone acts largely ...
... suspected, fast help is required. The first step is ... simple, identification of the pathogen; preferably, this test should ... laboratory. Portable miniature biodetection systems that can detect multiple ... American researchers from Lawrence Livermore National Laboratory led by ...
... microscope so powerful that it allows scientists peering ... nearly each individual protein they are studying has ... the Howard Hughes Medical Institute's Janelia Farm Research ... Institutes of Health and Florida State University. , ...
Cached Biology News:Computational analysis shows that plant hormones often go it alone 2Computational analysis shows that plant hormones often go it alone 3Encoded metallic nanowires reveal bioweapons 2New light microscope sharpens scientists' focus 2New light microscope sharpens scientists' focus 3New light microscope sharpens scientists' focus 4New light microscope sharpens scientists' focus 5New light microscope sharpens scientists' focus 6
... DNA isolation. Designed to hold ... well plate adapters from Mo Bio). ... plate length (max capacity is 192 ... for soil, microorganisms, animal tissue, plants, ...
... Chicken polyclonal to LYZL6 ( Abpromise ... Antigen: Synthetic peptide: ... HVDCQD , corresponding to amino acids ... Entrez Gene ID: 57151 ...
Drugs and NO-drug Rat Anti-conjugated Acetyl Salicylic Acid Polyclonal Antibody...
Request Info...
Biology Products: